These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2983789)

  • 1. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine binding in depressed patients with psychogenic pain.
    Mellerup ET; Dam H; Kim MY; Loldrup D; Plenge P; Rosenberg R; Schepelern S
    Psychiatry Res; 1990 Apr; 32(1):29-34. PubMed ID: 2161548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 6. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.
    Pharmacopsychiatry; 1990 May; 23(3):113-7. PubMed ID: 2165264
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet tritiated imipramine binding in patients suffering from mania.
    Ellis PM; Mellsop GW; Beeston R; Cooke RR
    J Affect Disord; 1991 Jul; 22(3):105-10. PubMed ID: 1655851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.
    Maj M; Mastronardi P; Cerreta A; Romano M; Mazzarella B; Kemali D
    Biol Psychiatry; 1988 Aug; 24(4):469-72. PubMed ID: 2841987
    [No Abstract]   [Full Text] [Related]  

  • 17. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.
    Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H
    Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H] imipramine binding sites are decreased in platelets of chronic pain patients.
    Magni G; Andreoli F; Arduino C; Arsie D; Ceccherelli F; Ambrosio F; Eandi M
    Acta Psychiatr Scand; 1987 Jan; 75(1):108-10. PubMed ID: 3033997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine binding in depression and other psychiatric conditions.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand Suppl; 1988; 345():61-8. PubMed ID: 2852451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.